Medtronic (NYSE: MDT) Q2 2025 Earnings Call Nov 19, 2024, 8:00 a.m. ET ...

Presentation Ryan Weispfenning, Vice President and Head of Medtronic Investor Relations at Medtronic Good morning. I'm Ryan ...

Mitral annular calcification with valve dysfunction remains a challenging syndrome. Operative risk is high, and available transcatheter therapies are limited. This study describes our initial ...

8 undervalued tech stocks offer attractive prices in a predominantly overvalued sector. Maintaining independence and editorial freedom is essential to our mission of empowering investor success ...

An emergency appeal has been instigated by Intrepid Travel following devastating flash floods which have killed almost 160 people in Spain. The not-for-profit Intrepid Foundation arm pledged to match ...

According to the evidence presented at trial, Doron Tavlin learned about a secret, pending acquisition by Medtronic of Mazor Robotics, where he worked as vice president of business development ...

It faced a setback in 2020 when Acurate Neo did not achieve noninferiority in a head-to-head trial against Medtronic’s TAVR device. Boston Scientific also discontinued its Lotus Edge TAVR platform in ...

Edwards Lifesciences, Medtronic and Inari Medical used this week’s Transcatheter Cardiovascular Therapeutics (TCT) conference in Washington, D.C., to share clinical trial data on their devices. Read ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...